Trudeau officials announced this week that the nonprofit biomedical research center has created a contract research organization that will make Trudeau's scientific resources available to biotechnology firms, pharmaceutical companies and academic researchers on a contractual basis.
As Chris Knight reports, Trudeau officials say the new endeavor will create more partnerships and diversify revenue.
The Department of Corrections will close two more prisons this year, bringing to a total of nine the number...
Law enforcement agencies from across the North Country took part in...
For years, scientists at Trudeau Institute have been contacted by pharmaceutical and biotech companies looking to use the institute's models to advance their own research. But Trudeau's scientists were often too busy with their own academic research to take on this additional work, according to Dawn Jelley-Gibbs, who will be managing Trudeau's new contract research program.
She said the loss of several faculty members at the Institute in recent years has freed up more opportunities for Trudeau to put its core resources to work for these companies, "Because we do have a couple fewer faculty members now than we had in the past couple of years, these cores do have extra labor resources," she said.
Those core resources include Trudeau's animal testing facilities, flow cytometry and molecular biology facilties, among others.
Jelley-Gibbs said contract research will help create a new revenue stream for the institute, which draws most of its funding through grants from the National Institutes of Health. "Revenue generated by all the cores and contract research at Trudeau certainly will help diversify the revenue that the institute has so we're not completely reliant on NIH funding and donations to conduct our academic research," she said.
Trudeau officials also said offering contract research services could lead to new research partnerships between the institute and the biotech and pharmaceutical companies its working with.
Jelley-Gibbs said she already has secured one agreement to do contract work for a biotech company and is in negotiation with a second.